Creative Biolabs Supplements Novel Single-domain Antibody Development with New Service Lines
Creative Biolabs, one of the leading service providers in the field of single-domain antibody (sdAb) development and downstream engineering, recently adds new solutions to supplement its sdAb development service lines, including services for multivalent sdAbs development and antibody humanization. New York, USA – April 27, 2022 – Studies show that single domain antibodies with multivalent,






